Market Overview

The global liquid biopsy market size was valued at USD 10.99 billion in 2024 and is projected to reach from USD 12.23 billion in 2025 to USD 28.84 billion by 2033, growing at a CAGR of 11.32% during the forecast period (2025-2033).

The global Liquid Biopsy market is witnessing swift transformation driven by new consumer behaviors, increased funding, and advancements in technology. According to Straits Research, the industry is further propelled by rising digital adoption, supportive government policies, expanding industrial applications, and a growing focus on operational efficiency and sustainability across markets. This section outlines the current market landscape, focusing on key trends, rising opportunities, major competitive actions, and the elements influencing the industry’s growth path.

Download Free Sample Report PDF (Includes Full TOC, Charts, Tables & Figures): https://straitsresearch.com/report/liquid-biopsy-market/request-sample

Market Scope and Research Approach

This study integrates both quantitative metrics and qualitative evaluations to provide a clear, accurate, and in-depth market assessment. The scope defines major parameters and market categories to give readers a structured view of the industry and its foundational dynamics.

The report analyzes market size, forecasts, and growth potential by evaluating essential segments and sub-segments. It explores critical market drivers, including regulatory policies, cost optimization, sustainability initiatives, and constant innovation. The analysis also includes competitive benchmarking, investment flow patterns, and policy frameworks influencing market evolution.

Regional Assessment

The research covers North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Each region is evaluated based on growth potential, market share, investment climate, and trade activity. Regional evaluations consider government initiatives, industry performance, demand shifts, and development prospects to provide a comprehensive geographic market view.

Download Free Sample Report PDF (Includes Full TOC, Charts, Tables & Figures): https://straitsresearch.com/report/liquid-biopsy-market/request-sample

Market Segmentation

1. By Product and Services
   1. Kits and Reagents
   2. Platforms and Instruments
   3. Services
2. By Circulating Biomarker
   1. Circulating Tumor Cells
   2. Extracellular Vesicles
   3. Circulating Tumor DNA [ctDNA]
3. By Cancer Type
   1. Lung Cancer
   2. Breast Cancer
   3. Colorectal Cancer
   4. Prostate Cancer
   5. Liver Cancer
4. By End-User
   1. Hospitals and Laboratories
   2. Government and Academic Research Centers

Major Market Participants

1. Bio-Rad Laboratories Inc.
2. Biocept Inc.
3. Guardant Health Inc.
4. Illumina Inc.
5. Hoffmann-La Roche Ltd. (Foundation Medicine Inc.)
6. Johnson & Johnson
7. Laboratory Corporation of America Holdings
8. Mdxhealth SA
9. Qiagen N.V.
10. Thermo Fisher Scientific Inc.

Download Free Sample Report PDF (Includes Full TOC, Charts, Tables & Figures): https://straitsresearch.com/report/liquid-biopsy-market/request-sample

Key Questions Addressed in the Liquid Biopsy Market Report:

• What is the current size of the Liquid Biopsy market?

• What is the projected size of the industry in the upcoming years?

• What is the estimated worldwide valuation of the Liquid Biopsy market?

• What is the market growth rate?

• Which market segment holds the largest share?

• What are the primary segments within the Liquid Biopsy market?

• What was the North American market valuation in 2024?

• Which region leads the global market?

• What factors are fueling market expansion?

• Who are the key industry participants?

• Which companies dominate the Liquid Biopsy landscape?

About Straits Research

Straits Research delivers in-depth market intelligence and data-driven insights across multiple industries. Our reports support decision-makers, investors, and organizations in identifying growth opportunities, overcoming challenges, and shaping strategic plans for sustained success in dynamic global markets.

"